WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the appointment of Gregory Perry as Senior Vice President and Chief Financial Officer (CFO). Mr. Perry succeeds Daniel Junius, who had been the Company’s CFO prior to his promotion.
